Ss Innovations International Inc. · NASDAQ:SSII
Ss Innovations International — Investor Presentation (June 2025)
32 slides from Ss Innovations International's investor presentation, Jun 3, 2025
Slide 1: We Build Advanced, Affordable and Accessible Surgical Robotic Solutions
We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2025 Nasdaq: SSII
Slide 2: Forward-Looking Statements
Forward - Looking Statements This Presentation contains forward - looking statements within the meaning of Section 27 A of the Securities Act of 1933 , as amended and Section 21 E of the Securities Exchange Act of 1934 , as amended . These statements involve known and unknown risks, uncertainties an
Slide 3: Snapshot of SS Innovations
Snapshot of SS Innovations • We develop innovative, differentiated surgical robotic technologies, highlighted by our: • proprietary, gold - standard surgical robotic system, “SSi Mantra 3” ; • comprehensive suite of surgical instruments , which support a variety of surgical procedures, including rob
Slide 4: Snapshot of SS Innovations (Continued)
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 4 Snapshot of SS Innovations (Continued) Headquarters Gurugram, India US Office New York, NY Employees (4/15/25) 378 Year Founded 2019 Year Merged with Avra Medical 2023 Ticker SSII Exchange Nasdaq Shares Out (5/13/25) 193.6 mm Recent Price (5/29/25) $6.03 M
Slide 5: Investment Highlights and Agenda
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 5 Investment Highlights and Agenda • Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology • Advanced, Surgical Robotics Technology Platform Validated Clinically and Commercially • Differentiated Product Offering , Inclu
Slide 6: Distinguished Leadership and Board with Proven Track Record
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 6 Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology Sudhir Srivastava, MD, Founder, Chairman, CEO & Director • Robotic Cardiac Surgeon • Pioneered many of the world’s first robotic cardiac procedures • 40+ years of s
Slide 7: Distinguished Leadership and Board with Proven Track Record
Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology Vishwajyoti Srivastava, MD, Chief Executive Officer - APAC • Columbia University • International College of Robotic Surgeons Arvind Palaniappan, Interim Chief Financial Officer • Chartered Accountant, Institu
Slide 8: Advanced SSi Mantra Intellectual Property
Advanced Surgical Robotics Technology Platform SSi Mantra 3 Intellectual Property Granted 5 Utility patents 30 Design patents Estimated data up to March 31, 2025 8 © 2025 SS INNOVATIONS INTERNATIONAL, INC. 69 Filed patent applications Trademarks Filed: 124; Registered: 53 Improved Patient Experience
Slide 9: Advanced SSi Mantra - Surgical Command Center
Advanced Surgical Robotics Technology Platform SSi Mantra 3 - Surgical Command Center Ergonomic Open - Faced Console Large 3D 4K Monitor Large 2D Touch Monitor for System Controls and DICOM access Lightweight Magnetic Hand Controls Design Head Tracking Safety Feature Digital Ergonomics Control Tele
Slide 10: Advanced SSi Mantra – Patient Side Robotic Arm Carts
Advanced Surgical Robotics Technology Platform SSi Mantra 3 – Patient Side Robotic Arm Carts Modular Robotic Carts Freedom of Patient Docking 3/4/5 Patient Cart Connectivity Absolute Stability Parking Locks Smaller Individual Cart Footprint Advanced Touch Screen Controls Multi - Specialty Use Includ
Slide 11: Advanced SSi Mantra – Vision Cart
Advanced Surgical Robotics Technology Platform SSi Mantra 3 – Vision Cart Large 3D 4K Monitor for OR Staff Inbuilt Multimedia Recording, Playback and Streaming Articulating Endoscope and Camera System Pre - Operative Guidance Software UPS Backup E - Stop Safety Features Standard 5 Robotic Arms Conne
Slide 12: Advanced SSi Mudra – Multi Specialty Robotic Instruments
Advanced Surgical Robotics Technology Platform SSi Mudra – Multi Specialty Robotic Instruments 7 Degrees of Freedom Articulating Robotic Instruments 10 Use Life Cycle per Instrument 20+ Cardiac Specialty Instruments 40+ Types of Instruments Novel Instrument: Automated Coronary Anastomotic Connector*
Slide 13: Advanced SSi Mudra – Cardiac Robotic Instruments
Advanced Surgical Robotics Technology Platform SSi Mudra – Cardiac Robotic Instruments 20+ Cardiac Specialty Instruments* Robotic Cardiac Surgery Potential Only company in the world actively advocating for robotic cardiac surgery Untapped market potential in automated coronary artery bypass surgery
Slide 14: Advanced SSi Maya – Mixed Reality and AI Enabled Technologies
Advanced Surgical Robotics Technology Platform SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI Enabled Technologies SSi Guru XR Tele Proctoring System • Mixed Reality Headset • Portable 3D Surgery Viewer • Interactive Virtual Screens • CDSCO Approved • Virtual Tele Illustration
Slide 15: Advanced World's First Robotic Cardiac Tele Surgery
Feb 2025 - SSI HQ – Gurugram, India Manipal Hospital – Jaipur, India 177 miles Mar 2025 - SSI HQ – Gurugram, India Aster CMI Hospital – Bengaluru, India 1,245 miles 15 © 2025 SS INNOVATIONS INTERNATIONAL, INC. Advanced Surgical Robotics Technology Platform World’s First Robotic Cardiac Tele Surgery
Slide 16: Advanced SSI Mantra M – Tele Surgery Mobile Unit
Advanced Surgical Robotics Technology Platform SSI Mantra M – Tele Surgery Mobile Unit Decentralizing and Democratizing access to Robotic surgery to global communities Enhances remote surgical access and empowers underserved communities through tele - surgery, surgical education, mentoring, and real
Slide 17: Advanced SSI Sutra – Centralized Data Registry System
Advanced Surgical Robotics Technology Platform SSI Sutra – Centralized Data Registry System Centralized digital platform designed to document, analyze, and streamline surgical workflows, clinical data, and procedural insights across the SSI Mantra robotic ecosystem. * Under Development 17 © 2025 SS
Slide 18: SS Innovations Advantages versus Leading Brand
Differentiated Product Offering, Including Optimal Cost - Effectiveness and Cardiac Surgery Capabilities SS Innovations Advantages versus Leading Brand 18 © 2025 SS INNOVATIONS INTERNATIONAL, INC. Leading Brand SSII Benefit Feature Surgeon Command Center No Yes Ergonomic posture optimizes surgeon co
Slide 19: Large and Growing Addressable Market with Favorable Industry Tailwinds
Large and Growing Addressable Market with Favorable Industry Tailwinds Market Expected to Increase from $5.1 Billion in 2024 with a CAGR of 11.7% to $15.5 Billion in 2034 1 No. of Multiport Surgical Robotic Systems Geography 6000+ North America 120+ South America 1500+ Europe 570+ Japan 350+ China 2
Slide 20: Accelerated Global Adoption of Robotic Surgery
Large and Growing Addressable Market with Favorable Industry Tailwinds Accelerated Global Adoption of Robotic Surgery Macro Trends • Large under - penetrated markets such as India, China, and other high - growth economies with rising incomes • Increase in healthcare spending and health insurance in
Slide 21: Access to Robotic Surgery Remains Limited
Large and Growing Addressable Market with Favorable Industry Tailwinds Access to Robotic Surgery Remains Limited Benefits of Robotic Surgery In the 20 Years Since Launch of Robotic Surgery, Access Remains Limited: Installed base largely limited to the US, EU and Japan 7 billion people have access to
Slide 22: Unmet Needs and Accessibility Challenges Support Our Foundational Market in India
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 22 Large and Growing Addressable Market with Favorable Industry Tailwinds Unmet Needs and Accessibility Challenges Support Our Foundational Market in India ~ 60,000 Robot Assisted Surgeries have been performed in India as of 2024 Since 2002, Only 296 Surgica
Slide 23: World-Class R&D and Manufacturing Facilities to Support Growth
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 23 World - Class R&D and Manufacturing Facilities to Support Growth Cost - Effective, State - of - the - Art R&D and Manufacturing Facilities in India R&D, Manufacturing, Assembly, and Operations in Gurgaon, Delhi National Capital Region (India) Proximity to
Slide 24: SS Innovations vs Competitor Installations in India
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 24 Stronghold in India, Global Expansion Underway with Near - Term Catalysts Anticipated in the EU and US SS Innovations vs Competitor Installations in India* Launch Date Company August 2022 SS Innovations September 2021 Medtronic October 2019 CMR December 2
Slide 25: Global Expansion - Quality and Regulatory Approvals
Stronghold in India, Global Expansion Underway with Near - Term Catalysts Anticipated in the EU and US Global Expansion - Quality and Regulatory Approvals India CDSCO Nepal Ecuador Guatemala Philippines Indonesia Ukraine Colombia Sri Lanka US FDA EU CE EN ISO 13485 In 2024, SS Innovations generated
Slide 26: EU CE Mark - Estimated Timeline
Stronghold in India, Global Expansion Underway with Near - Term Catalysts Anticipated in the EU and US EU CE Mark - Estimated Timeline Route of conformity to Notified body Certification EN ISO 13485 Completed Stage 1 Audit Desktop April 2025 Stage 2 Audit On Site June 2025 CE Marking Nov/Dec 2025* I
Slide 27: US FDA – Estimated Timeline
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 27 Stronghold in India, Global Expansion Underway with Near - Term Catalysts Anticipated in the EU and US US FDA – Estimated Timeline FDA Q Sub Regulatory Strategy Feedback, Biocompatibility, Reprocessing 2024 Current Stage De Novo Classification Request dos
Slide 28: Early Innings of Exponential Sales Growth, Expanding Margins, Recurring Revenue
© 2025 SS INNOVATIONS INTERNATIONAL, INC. 28 Early Innings of Exponential Sales Growth, Expanding Margins and Increasing Mix of Recurring Revenue $5.9 $20.6 2023 2024 Annual Revenue ($ millions) Gross Margin (%) Recurring Revenue 1 (%) 12.35% 40.93% 2023 2024 94% 6% $20.6 mm Revenue 2024 Systems/Oth
Slide 29: Strategy to Deliver Long-Term, Sustainable Growth
Strategy to Deliver Long - Term, Sustainable Growth Emphasis on Organic Growth 29 © 2025 SS INNOVATIONS INTERNATIONAL, INC. Continuously Improve and Innovate Our Top - Tier Robotics Platform through New Product Development and Enhanced Technology . Maintain Stronghold in India , Grow in Select Under
Slide 30: Conclusions
Conclusions 30 © 2025 SS INNOVATIONS INTERNATIONAL, INC. • Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology • Advanced, Surgical Robotics Technology Platform Validated Clinically and Commercially • Differentiated Product Offering , Including Optimal Cost -
Slide 31: Financial Summary
Financial Summary 31 © 2025 SS INNOVATIONS INTERNATIONAL, INC. Three Months Ended Twelve Months Ended SS Innovations March 31, 2025 March 31, 2024 December 31, 2024 December 31, 2023 Statement of Operations 5,120,610 3,637,693 20,649,528 5,875,314 Revenue 1,087,208 728,182 8,452,366 725,528 Gross Pr
Slide 32: Investor Contact
www.ssinnovations.com investors@ssinnovations.org Investor Contact: Kalle Ahl, CFA (303) 953 - 9878 kahl@theequitygroup.com 32 © 2025 SS INNOVATIONS INTERNATIONAL, INC.
SS Innovations International — Investor Presentation (June 2025) on 6ix